Bioanalytical screening methods for dioxins and dioxin-like compounds a review of bioassay/biomarker technology.
about
The 2005 World Health Organization reevaluation of human and Mammalian toxic equivalency factors for dioxins and dioxin-like compoundsDifferent levels of polybrominated diphenyl ethers (PBDEs) and chlorinated compounds in breast milk from two U.K. RegionsDevelopment of Species-Specific Ah Receptor-Responsive Third Generation CALUX Cell Lines with Enhanced Responsiveness and Improved Detection LimitsCommon commercial and consumer products contain activators of the aryl hydrocarbon (dioxin) receptorCompound- and mixture-specific differences in resistance to polycyclic aromatic hydrocarbons and PCB-126 among Fundulus heteroclitus subpopulations throughout the Elizabeth River estuary (Virginia, USA)A modified QuEChERS approach for the screening of dioxins and furans in sediments.Electrochemical sensor for multiplex biomarkers detectionRelative potency for altered humoral immunity induced by polybrominated and polychlorinated dioxins/furans in female B6C3F1/N mice.Analysis of dioxins in contaminated soils with the calux and caflux bioassays, an immunoassay, and gas chromatography/high-resolution mass spectrometry.Assessment of dioxin-like soil contamination in Mexico by enzyme-linked immunosorbent assay.Considerations for potency equivalent calculations in the Ah receptor-based CALUX bioassay: normalization of superinduction results for improved sample potency estimation.Enhancing the response of CALUX and CAFLUX cell bioassays for quantitative detection of dioxin-like compounds.Saliva: diagnostics and therapeutic perspectivesEffect based monitoring of seasonal ambient air exposures in Australia sampled by PUF passive air samplersAnalytical methods for PCBs and organochlorine pesticides in environmental monitoring and surveillance: a critical appraisal.Third-generation Ah receptor-responsive luciferase reporter plasmids: amplification of dioxin-responsive elements dramatically increases CALUX bioassay sensitivity and responsiveness.CALUX bioassay: a cost-effective rapid screening technique for screening dioxins like compounds.Characteristics and application of established luciferase hepatoma cell line that responds to dioxin-like chemicals.AhR transcriptional activity in serum of Inuits across Greenlandic districts.Immunoanalysis methods for the detection of dioxins and related chemicals.Effect of β-naphthoflavone on hepatic cytochrome P4501A activity in the scribbled rabbitfish (Siganus spinus) from tropical Indo-Pacific coral reefs.Phenolics: occurrence and immunochemical detection in environment and food.A review on the practical application of human biomonitoring in integrated environmental health impact assessment.Development of a highly specific amine-terminated aptamer functionalized surface plasmon resonance biosensor for blood protein detection.Bioanalytical and instrumental screening of the uptake of sediment-borne, dioxin-like compounds in roach (Rutilus rutilus).Characterization of AhR agonist compounds in roadside snow.Exposure time-dependent effects on the relative potencies and additivity of PAHs in the Ah receptor-based H4IIE-luc bioassay.Biomonitoring of detoxifying activity as measured by CYP1A1 induction in Yangtze and Jialing Rivers in Chongqing City in China.Persistent organic pollutants and related biological responses measured in coastal fish using chemical and biological screening methods.Quantitative structure-activity relationships for the prediction of relative in vitro potencies (REPs) for chloronaphthalenes.Computational prediction of 7-ethoxyresorufin-O-diethylase (EROD) and luciferase (luc) inducing potency for 75 congeners of chloronaphthalene.Exposure to environmental toxins in mothers of children with autism spectrum disorder.Water-quality monitoring technique for dioxins during dredging using on-site solid phase extraction with graphitic carbon and analysis with DR-CALUX.In vitro assessment of retinoic acid and aryl hydrocarbon receptor activity of treated effluent from 39 wastewater-treatment plants in Victoria, Australia.Rapid screening method for determination of PCDDs and PCDFs in fly ashes using GC-ion trap MS/MS based on cellular disruptor extraction.β-Naphthoflavone-Induced Mitochondrial Respiratory Damage in Cyp1 Knockout Mouse and in Cell Culture Systems: Attenuation by Resveratrol Treatment.Effect-based assessment of passive air samples from four countries in Eastern Europe.Revised relative potency values for PCDDs, PCDFs, and non-ortho-substituted PCBs for the optimized H4IIE-luc in vitro bioassay.Applicability of the CALUX bioassay for screening of dioxin levels in human milk samples.Kynurenine Modulates MMP-1 and Type-I Collagen Expression Via Aryl Hydrocarbon Receptor Activation in Dermal Fibroblasts.
P2860
Q24657959-A29EE2FC-B597-4A5D-BCBB-4DD5C71AD372Q24815138-EA31F301-B92D-4B80-A707-8045A47B3625Q28388445-B8C21149-2C44-4D97-94A3-9267B5F9DFAFQ28394557-C6DC0336-FB45-4B37-9056-0373A15B9649Q28656360-23E477B3-065B-43E2-8812-72C68ED1904EQ31070400-8C26A301-03D6-42C1-B477-F686217155A4Q33563305-CD455292-C200-49B4-863E-285034E0F9D7Q33652479-3C38D6D9-24A5-49D6-A78D-26B8C983C15EQ33807579-E8127B61-2987-4153-9AF9-7456A506B9F7Q34550394-040B13DA-0534-456D-923A-F2D591E8AE91Q34564136-E2150D85-7A0D-4DDA-B143-192305657866Q34626587-D551C184-42D2-4B25-AD19-B7B640C14D90Q34669417-3066F40A-594A-4E0A-B869-B8B95DD8FED0Q34920184-E501CA39-5D79-4A38-BCB3-D10A68867E2CQ35230030-7B520D77-62A8-452B-B2DD-DD24D8269E52Q35231091-DC6C1AFA-9E62-4488-ACBC-720392DEF9AAQ35946197-13E834F4-3E17-46E6-9F67-25BB64811D4AQ36190635-753991B6-CE04-4864-9FEE-1BEF1AA1D4FAQ36325289-F79A8161-20F3-4C2B-9843-3416B45F78BFQ36608237-E1B9A712-F3D2-45CC-B479-B18CF68FBEE6Q37325939-90390C36-883F-45EB-9C7F-D4D78C0B6A1DQ37374192-9FE75287-F024-4D1F-B457-67E8BBACB875Q37398936-97A0D2DE-3CF0-4023-80ED-58C52B3D48E9Q38607452-146225CE-0C53-4CE3-86E4-21ED6654BE75Q38787218-0A95D12A-5CC6-4258-AAA1-5F21CEEC6982Q39118189-0EA22311-CFCB-4A48-A046-321851E65BA6Q39397576-CE875C90-A6C3-42AD-BB2E-971DE509AF8AQ39843445-F897900C-5EEC-473E-9584-11B741927E62Q40041123-0621BF5B-94F5-42D0-8D1F-B11A3A3EB4B0Q40141965-E5D6083E-CA7C-463E-ADAB-0E76AD141687Q40497776-51671422-43E0-43B0-84CD-F75004B16307Q41361101-81AC7FA2-87CF-491B-A4B0-292D56337999Q43094294-C583C040-1E95-417A-9B58-033DE0584B76Q43328150-49BC377B-6B0D-431D-B090-5C1512F77FCCQ43335673-48428B33-3CE6-4417-9CFD-670DD59AB9F7Q43372982-229559D0-C2FA-4DEE-9992-5A7681B17FBBQ43640282-5120FCBE-4F42-4CC7-9B92-D10A0346DF27Q44252031-AFAB74CF-CB13-427E-BAAA-06489261934AQ44525790-C3D9B24D-5E1B-423C-9A71-9A528AC08A56Q51435084-26BEFD3F-6C58-40DD-AA13-086BEAA63C5A
P2860
Bioanalytical screening methods for dioxins and dioxin-like compounds a review of bioassay/biomarker technology.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Bioanalytical screening method ...... bioassay/biomarker technology.
@ast
Bioanalytical screening method ...... bioassay/biomarker technology.
@en
Bioanalytical screening method ...... bioassay/biomarker technology.
@nl
type
label
Bioanalytical screening method ...... bioassay/biomarker technology.
@ast
Bioanalytical screening method ...... bioassay/biomarker technology.
@en
Bioanalytical screening method ...... bioassay/biomarker technology.
@nl
prefLabel
Bioanalytical screening method ...... bioassay/biomarker technology.
@ast
Bioanalytical screening method ...... bioassay/biomarker technology.
@en
Bioanalytical screening method ...... bioassay/biomarker technology.
@nl
P2093
P1476
Bioanalytical screening method ...... bioassay/biomarker technology.
@en
P2093
P304
P356
10.1016/S0160-4120(01)00028-9
P577
2001-11-01T00:00:00Z